89
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Nomogram to Predict the Occurrence and Prognosis of Distant Metastasis in T1N0 Colon Cancer: A SEER Data-Based Study

, , , , , , , , ORCID Icon, , ORCID Icon & ORCID Icon show all
Pages 9131-9143 | Published online: 30 Nov 2021

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34. doi:10.3322/caac.21551
  • Yang Y, Lu Y, Jiang W, et al. Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer. World J Surg Oncol. 2020;18:193. doi:10.1186/s12957-020-01972-y
  • Nozawa H, Ishihara S, Kawai K, et al. Conversion to resection in patients receiving systemic chemotherapy for unresectable and/or metastatic colorectal cancer-predictive factors and prognosis. Clin Colorectal Cancer. 2018;17:e91–e97. doi:10.1016/j.clcc.2017.10.002
  • Dang H, de Vos Tot Nederveen Cappel WH, van der Zwaan SMS, et al. Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection. Gastrointest Endosc. 2019;89:533–544.
  • Senore C, Giovo I, Ribaldone DG, et al. Management of Pt1 tumours removed by endoscopy during colorectal cancer screening: outcome and treatment quality indicators. Eur J Surg Oncol. 2018;44:1873–1879. doi:10.1016/j.ejso.2018.09.009
  • Guo K, Feng Y, Yuan L, et al. Risk factors and predictors of lymph nodes metastasis and distant metastasis in newly diagnosed T1 colorectal cancer. Cancer Med. 2020;9:5095–5113. doi:10.1002/cam4.3114
  • Sun ZQ, Ma S, Zhou QB, et al. Prognostic value of lymph node metastasis in patients with T1-stage colorectal cancer from multiple centers in China. World J Gastroenterol. 2017;23:8582–8590. doi:10.3748/wjg.v23.i48.8582
  • Saitoh Y, Inaba Y, Sasaki T, et al. Management of colorectal T1 carcinoma treated by endoscopic resection. Dig Endosc. 2016;28:324–329. doi:10.1111/den.12503
  • Wada H, Shiozawa M, Katayama K, et al. Systematic review and meta-analysis of histopathological predictive factors for lymph node metastasis in T1 colorectal cancer. J Gastroenterol. 2015;50:727–734. doi:10.1007/s00535-015-1057-0
  • Camp R, Dolled-Filhart M, Rimm D. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10:7252–7259. doi:10.1158/1078-0432.CCR-04-0713
  • Malvezzi M, Carioli G, Bertuccio P, et al. European cancer mortality predictions for the year 2018 with focus on colorectal cancer. Ann Oncol. 2018;29:1016–1022. doi:10.1093/annonc/mdy033
  • Chiu HM, Chen SL, Yen AM, et al. Effectiveness of fecal immunochemical testing in reducing colorectal cancer mortality from the one million Taiwanese screening program. Cancer. 2015;121:3221–3229. doi:10.1002/cncr.29462
  • Yantiss R, Goodarzi M, Zhou X, et al. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol. 2009;33:572–582. doi:10.1097/PAS.0b013e31818afd6b
  • Kornprat P, Pollheimer M, Lindtner R, et al. Value of tumor size as a prognostic variable in colorectal cancer: a critical reappraisal. Am J Clin Oncol. 2011;34:43–49. doi:10.1097/COC.0b013e3181cae8dd
  • Lou Z, Meng RG, Zhang W, et al. Preoperative carcinoembryonic antibody is predictive of distant metastasis in pathologically T1 colorectal cancer after radical surgery. World J Gastroenterol. 2013;19:389–393. doi:10.3748/wjg.v19.i3.389
  • Kim CW, Baek JH, Choi GS, et al. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous unresectable metastasis: study protocol for a randomized controlled trial. Trials. 2016;17:34. doi:10.1186/s13063-016-1164-0
  • Ichikawa Y, Goto A, Kobayashi N, et al. Does resection of primary lesions show survival benefit for stage IV colorectal cancer patients with unresectable metastases? Hepatogastroenterology. 2013;60:1945–1949.
  • Shimomura M, Okajima M, Hinoi T, et al. Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer. Int J Colorectal Dis. 2012;27:1339–1346. doi:10.1007/s00384-012-1454-2
  • Park JH, Kim TY, Lee KH, et al. The beneficial effect of palliative resection in metastatic colorectal cancer. Br J Cancer. 2013;108:1425–1431. doi:10.1038/bjc.2013.94
  • Yeom SS, Lee SY, Kwak HD, et al. The outcome of primary tumor resection in the unresectable stage IV colorectal cancer patients who received the bevacizumab-containing chemotherapy. Medicine. 2020;99:e19258. doi:10.1097/MD.0000000000019258
  • Ha GW, Kim JH, Lee MR. Meta-analysis of oncologic effect of primary tumor resection in patients with unresectable stage IV colorectal cancer in the era of modern systemic chemotherapy. Ann Surg Treat Res. 2018;95:64–72. doi:10.4174/astr.2018.95.2.64
  • Chan TW, Brown C, Ho CC, et al. Primary tumor resection in patients presenting with metastatic colorectal cancer: analysis of a provincial population-based cohort. Am J Clin Oncol. 2010;33:52–55. doi:10.1097/COC.0b013e31819e902d
  • Alawadi Z, Phatak UR, Hu CY, et al. Comparative effectiveness of primary tumor resection in patients with stage IV colon cancer. Cancer. 2017;123:1124–1133. doi:10.1002/cncr.30230
  • Hasegawa S, Takashimizu K, Fujita S, et al. [A study of 10 patients with unresectable colorectal cancer who achieved long-term survival]. Gan To Kagaku Ryoho. 2013;40:1978–1980. Japanese.
  • Park EJ, Baek JH, Choi GS, et al. The role of primary tumor resection in colorectal cancer patients with asymptomatic, synchronous, unresectable metastasis: a multicenter randomized controlled trial. Cancers. 2020;12:2306. doi:10.3390/cancers12082306
  • Kim NK. Paradigm shift in the treatment of elderly patients with unresectable stage IV colorectal cancer. Ann Coloproctol. 2014;30:155–156. doi:10.3393/ac.2014.30.4.155